Calcium channel blockers: the present and the future (original) (raw)

The role of calcium channel blockers in the treatment of hypertension

Luigi Cubeddu

American Heart Journal, 1986

View PDFchevron_right

Calcium channel blockers and hypertension

Allegra Battistoni

Journal of cardiovascular pharmacology and therapeutics, 2015

View PDFchevron_right

Use of Calcium Channel Blockers in Cardiovascular Risk Reduction

Julio Acosta

American Journal Cardiovascular Drugs, 2010

View PDFchevron_right

Efficacy and safety of the dual L- and T-type calcium channel blocker, ACT-280778: a proof-of-concept study in patients with mild-to-moderate essential hypertension

Jasper Dingemanse

Journal of human hypertension, 2015

View PDFchevron_right

Efficacy and safety of ACT-280778, a dual L- and T-type calcium channel blocker, in patients with mild-to-moderate essential hypertension: results from a phase 2a, randomized, double-blind, placebo- and active-controlled trial (REDUCE–1)

Jasper Dingemanse

View PDFchevron_right

Calcium antagonists: Not appropriate as first line antihypertensive agents

Curt Furberg

1996

View PDFchevron_right

Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175 634 patients

Caterina Marciano

Journal of Hypertension, 2009

View PDFchevron_right

A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease

José Cangiano

JAMA, 2003

View PDFchevron_right

Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension

Joseph Diamond

American journal of hypertension, 2001

View PDFchevron_right

Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension* 1

Milena Henzlova

American journal of …, 2001

View PDFchevron_right

Efficacy and Safety of Dual Calcium Channel Blockade for the Treatment of Hypertension: A Meta-Analysis

A. Benjo

2013

View PDFchevron_right

Effectiveness and safety assessment of beta-blockers, calcium channel blockers, and angiotensin receptor blockers in hypertensive patients: a prospective study

Dhruvi Pandit

American journal of cardiovascular disease, 2021

View PDFchevron_right

Evolving role of calcium antagonists in themanagement of hypertension

Vito Campese

Medical Clinics of North America, 2004

View PDFchevron_right

Reduction of blood pressure by store-operated calcium channel blockers

Vijayan Elimban

Journal of cellular and molecular medicine, 2015

View PDFchevron_right

Calcium channel blockers in systemic hypertension

Jack A Stroh

The American Journal of Cardiology, 1986

View PDFchevron_right

Update on the use of calcium antagonists on hypertension

R. Hernández

Journal of Human Hypertension, 2002

View PDFchevron_right

Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: A scientific statement from the Asian Pacific Heart Association

Tzung-dau Wang

Hypertension Research, 2011

View PDFchevron_right

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT

Luis Miguel

Lancet, 2000

View PDFchevron_right

Southwestern Internal Medicine Conference: Calcium Antagonists in the Treatment of Hypertension

Yoram Yagil

The American Journal of the Medical Sciences, 1985

View PDFchevron_right

How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension

Elisa Roca

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2017

View PDFchevron_right

Management of Hypertension- Insights Into Real-World Clinical Practice for Differential Usage of Calcium Channel Blockers (CCBS)

Arup Dasbiswas

Journal of Evidence Based Medicine and Healthcare

View PDFchevron_right

Comparison of the Effect of Calcium Channel Blockers and Non-selective Beta-Blockers on Blood Lipids in Hypertensive Patients

Ghulam Murtaza

View PDFchevron_right

The pharmacological basis for the combination of calcium channel antagonists and angiotensin converting enzyme inhibitors in the treatment of hypertension

Bernd Mühlbauer

Journal of Hypertension, 1995

View PDFchevron_right

Current Treatment of Patients with Hypertension

Stefano Taddei

Drugs, 2003

View PDFchevron_right

Calcium Antagonists: Effects on Cardio-Renal Risk in Hypertensive Patients

Sandeep Nathan

Hypertension, 2005

View PDFchevron_right

Prospective study of calcium channel blocker use, cardiovascular disease, and total mortality among hypertensive women: the Nurses' Health Study

Alec Walker

Circulation, 1998

View PDFchevron_right

Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis

Lecteurs Sablon

View PDFchevron_right

Comparisons of Increasing Calcium Channel Blocker dose and Adding Thiazide Diuretic in Hypertensive Patients Given Medium-dose Angiotensin II Receptor Blocker and Amlodipine

Akihiro Tojo

Dokkyo journal of medical sciences, 2017

View PDFchevron_right

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

J. Lanke

Lancet, 2000

View PDFchevron_right